Annual Cash & Cash Equivalents
$3.47 M
-$4.85 M-58.33%
01 December 2023
Summary:
Creative Medical Technology Holdings annual cash & cash equivalents is currently $3.47 million, with the most recent change of -$4.85 million (-58.33%) on 01 December 2023. During the last 3 years, it has fallen by -$7.26 million (-67.67%). CELZ annual cash & cash equivalents is now -67.67% below its all-time high of $10.72 million, reached on 31 December 2021.CELZ Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$6.26 M
-$1.21 M-16.21%
01 September 2024
Summary:
Creative Medical Technology Holdings quarterly cash and cash equivalents is currently $6.26 million, with the most recent change of -$1.21 million (-16.21%) on 01 September 2024. Over the past year, it has increased by +$2.79 million (+80.58%). CELZ quarterly cash and cash equivalents is now -72.62% below its all-time high of $22.86 million, reached on 01 June 2022.CELZ Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CELZ Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +80.6% |
| 3 y3 years | -67.7% | -41.6% |
| 5 y5 years | +3813.0% | +6965.9% |
CELZ Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -67.7% | at low | -72.6% | +80.6% |
| 5 y | 5 years | -67.7% | +3813.0% | -72.6% | >+9999.0% |
| alltime | all time | -67.7% | -72.6% | >+9999.0% |
Creative Medical Technology Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.26 M(-16.2%) |
| June 2024 | - | $7.47 M(-17.1%) |
| Mar 2024 | - | $9.01 M(+159.8%) |
| Dec 2023 | $3.47 M(-58.3%) | $3.47 M(-23.1%) |
| Sept 2023 | - | $4.51 M(+13.0%) |
| June 2023 | - | $3.99 M(-58.1%) |
| Mar 2023 | - | $9.52 M(+14.4%) |
| Dec 2022 | $8.32 M(-22.4%) | $8.32 M(-51.0%) |
| Sept 2022 | - | $16.97 M(-25.8%) |
| June 2022 | - | $22.86 M(+150.0%) |
| Mar 2022 | - | $9.15 M(-14.7%) |
| Dec 2021 | $10.72 M(>+9900.0%) | - |
| Dec 2021 | - | $10.72 M(+351.0%) |
| Sept 2021 | - | $2.38 M(+1399.3%) |
| June 2021 | - | $158.60 K(-42.3%) |
| Mar 2021 | - | $275.10 K(+180.7%) |
| Dec 2020 | $98.00 K(+10.6%) | $98.00 K(+153.2%) |
| Sept 2020 | - | $38.70 K(+4.6%) |
| June 2020 | - | $37.00 K(-3.4%) |
| Mar 2020 | - | $38.30 K(-56.8%) |
| Dec 2019 | $88.60 K(-70.9%) | $88.60 K(-44.0%) |
| Sept 2019 | - | $158.20 K(-22.5%) |
| June 2019 | - | $204.10 K(-51.3%) |
| Mar 2019 | - | $419.50 K(+37.9%) |
| Dec 2018 | $304.10 K(+2119.7%) | $304.10 K(+76.0%) |
| Sept 2018 | - | $172.80 K(+71.9%) |
| June 2018 | - | $100.50 K(-1.8%) |
| Mar 2018 | - | $102.30 K(+646.7%) |
| Dec 2017 | $13.70 K(-93.8%) | $13.70 K(-35.4%) |
| Sept 2017 | - | $21.20 K(-79.7%) |
| June 2017 | - | $104.40 K(+6.4%) |
| Mar 2017 | - | $98.10 K(-55.8%) |
| Dec 2016 | $221.90 K | $221.90 K(+562.4%) |
| Sept 2016 | - | $33.50 K(+29.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $25.80 K(>+9900.0%) |
| Mar 2016 | - | $200.00(0.0%) |
| Dec 2015 | $200.00(-80.0%) | $200.00(-71.4%) |
| Sept 2015 | - | $700.00(+16.7%) |
| June 2015 | - | $600.00(0.0%) |
| Mar 2015 | - | $600.00(-40.0%) |
| Dec 2014 | $1000.00(+150.0%) | $1000.00(-23.1%) |
| Sept 2014 | - | $1300.00(0.0%) |
| June 2014 | - | $1300.00(0.0%) |
| Mar 2014 | - | $1300.00(+225.0%) |
| Dec 2013 | $400.00(-50.0%) | $400.00(0.0%) |
| Sept 2013 | - | $400.00(0.0%) |
| June 2013 | - | $400.00(-33.3%) |
| Mar 2013 | - | $600.00(-25.0%) |
| Dec 2012 | $800.00(-27.3%) | $800.00(0.0%) |
| Sept 2012 | - | $800.00(+60.0%) |
| June 2012 | - | $500.00(-16.7%) |
| Mar 2012 | - | $600.00(-45.5%) |
| Dec 2011 | $1100.00(+175.0%) | $1100.00(-8.3%) |
| Sept 2011 | - | $1200.00(+200.0%) |
| June 2011 | - | $400.00(+33.3%) |
| Mar 2011 | - | $300.00(-25.0%) |
| Dec 2010 | $400.00(-33.3%) | $400.00(+33.3%) |
| Sept 2010 | - | $300.00(+200.0%) |
| June 2010 | - | $100.00(0.0%) |
| Mar 2010 | - | $100.00(-83.3%) |
| Dec 2009 | $600.00(+100.0%) | $600.00(+50.0%) |
| Sept 2009 | - | $400.00(-50.0%) |
| June 2009 | - | $800.00(+700.0%) |
| Mar 2009 | - | $100.00(-66.7%) |
| Dec 2008 | $300.00(-98.6%) | $300.00(-97.1%) |
| Sept 2008 | - | $10.40 K(-52.3%) |
| Dec 2007 | $21.80 K(>+9900.0%) | $21.80 K |
| Dec 2006 | $0.00 | - |
FAQ
- What is Creative Medical Technology Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings quarterly cash and cash equivalents year-on-year change?
What is Creative Medical Technology Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of CELZ is $3.47 M
What is the all time high annual cash & cash equivalents for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high annual cash & cash equivalents is $10.72 M
What is Creative Medical Technology Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CELZ is $6.26 M
What is the all time high quarterly cash and cash equivalents for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high quarterly cash and cash equivalents is $22.86 M
What is Creative Medical Technology Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, CELZ quarterly cash and cash equivalents has changed by +$2.79 M (+80.58%)